Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BioVie Inc. (BIVI)

2.18   -0.02 (-0.91%) 09-24 14:53
Open: 2.19 Pre. Close: 2.2
High: 2.23 Low: 1.96
Volume: 86,804 Market Cap: 63(M)
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Carson City, Nevada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.23 - 2.25 2.25 - 2.26
Low: 1.93 - 1.95 1.95 - 1.96
Close: 2.16 - 2.18 2.18 - 2.2

Technical analysis

as of: 2022-09-23 4:22:35 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.94     One year: 4.96
Support: Support1: 1.96    Support2: 1.63
Resistance: Resistance1: 3.37    Resistance2: 4.25
Pivot: 2.6
Moving Average: MA(5): 2.22     MA(20): 2.74
MA(100): 2.3     MA(250): 3.72
MACD: MACD(12,26): -0.2     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 7.5     %D(3): 5.1
RSI: RSI(14): 40.4
52-week: High: 7.59  Low: 1.32
Average Vol(K): 3-Month: 343 (K)  10-Days: 180 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ BIVI ] has closed above bottom band by 20.1%. Bollinger Bands are 39.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 21 Sep 2022
Hareem Farooq shares a fun reel with fans - Daily Pakistan Global

Thu, 08 Sep 2022
Wall Street analysts' outlook for BioVie Inc. (BIVI) - SETE News

Wed, 07 Sep 2022
What Is Going on With Sidus Space (SIDU) Stock Today? - InvestorPlace

Wed, 07 Sep 2022
Is Tandy Leather Factory (TLFA) Stock the Next Big Squeeze? - InvestorPlace

Wed, 07 Sep 2022
What Is Going on With Getty Images (GETY) Stock Today? - InvestorPlace

Wed, 07 Sep 2022
Thinking about buying stock in Spero Therapeutics, Quoin Pharmaceuticals, BioVie, Reviva Pharmaceuticals, - Benzinga

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 25 (M)
% Held by Insiders 4.48e+006 (%)
% Held by Institutions 94.2 (%)
Shares Short 66 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.4933e+008
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -478.4
Return on Equity (ttm) -1
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 152.19
EBITDA (p.s.) 0
Qtrly Earnings Growth -6.7
Operating Cash Flow 0 (M)
Levered Free Cash Flow -20 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0.01
Price to Cash Flow 14.33

Stock Dividends

Dividend 0
Forward Dividend 69460
Dividend Yield 0%
Dividend Pay Date 2019-11-21
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.